2017 | Beyond precision surgery: Molecularly motivated precision care for gastric cancer | EJSO |
2014 | Characteristics of combined hepatocelluar-cholangiocarcinoma and comparison with intrahepatic cholangiocarcinoma | EJSO |
2020 | Clinical implication of tumor site in terms of node metastasis for intrahepatic cholangiocarcinoma
| EJSO |
2017 | Correlation between lymph node count and survival and a reappraisal of lymph node ratio as a predictor of survival in gastric cancer: A multi-institutional cohort study | EJSO |
2022 | Does laparoscopy increase the risk of peritoneal recurrence after resection for pT4 colon cancer? Results of a propensity score-matched analysis from an international cohort | EJSO |
2019 | European validation of the Yonsei Gastric Cancer Prognosis Prediction Model after gastrectomy: Validation with the Netherlands Cancer Registry | EJSO |
2007 | Factors influencing operation time of laparoscopy-assisted distal subtotal gastrectomy: analysis of consecutive 100 initial cases | EJSO |
2023 | Impact of body mass index on the difficulty and outcomes of laparoscopic left lateral sectionectomy | EJSO |
2023 | Impact of liver cirrhosis and portal hypertension on minimally invasive limited liver resection for primary liver malignancies in the posterosuperior segments: An international multicenter study | EJSO |
2023 | Impact of neoadjuvant chemotherapy on the difficulty and outcomes of laparoscopic and robotic major liver resections for colorectal liver metastases: A propensity-score and coarsened exact-matched controlled study | EJSO |
2012 | Impact of pretreatment thrombocytosis on blood-borne metastasis and prognosis of gastric cancer. | EJSO |
2021 | Incidence and treatment outcomes of leakage after gastrectomy for gastric cancer: Experience of 14,075 patients from a large volume centre | EJSO |
2006 | Intraoperative examination of sentinel lymph nodes by immunohistochemical staining in patients with breast cancer | EJSO |
2022 | No detrimental effect of perioperative blood transfusion on recurrence in 2905 stage II/III gastric cancer patients: A propensity-score matching analysis | EJSO |
2016 | Optimal assessment of lymph node status in gallbladder cancer | EJSO |
2021 | Perioperative, short-, and long-term outcomes of gastric cancer surgery: Propensity score-matched analysis of patients with or without prior solid organ transplantation | EJSO |
2020 | Prognostic significance of body mass index and prognostic nutritional index in stage II/III gastric cancer | EJSO |
2014 | Rapid and safe learning of robotic gastrectomy for gastric cancer: Multidimensional analysis in a comparison with laparoscopic gastrectomy | EJSO |
2016 | Re: Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with lobaplatin and docetaxel to treat synchronous peritoneal carcinomatosis from gastric cancer: Results from a Chinese center, Eur J Surg Oncol (2016) | EJSO |
2021 | Reply to: Letter to Roh CK et al. 'Incidence and treatment outcomes of leakage after gastrectomy for gastric cancer: Experience of 14,075 patients from a large volume centre' | EJSO |
2014 | Risk factors for double primary malignancies and their clinical implications in patients with sporadic gastric cancer | EJSO |
2022 | Survival benefit from axillary surgery in patients aged 70 years or older with clinically node-negative breast cancer: A population-based propensity-score matched analysis | EJSO |
2021 | The Delphi and GRADE methodology used in the PSOGI 2018 consensus statement on Pseudomyxoma Peritonei and Peritoneal Mesothelioma | EJSO |
2011 | The efficacy of portal vein embolization prior to right extended hemihepatectomy for hilar cholangiocellular carcinoma: a retrospective cohort study. | EJSO |
2021 | Upfront chemotherapy and short-course radiotherapy with delayed surgery for locally advanced rectal cancer with synchronous liver metastases | EJSO |